Berkshire Hathaway Record $11B Buyback Reanalysis: Why the Largest Repurchase in Company History Reframes the BRK.B Fair-Value Debate at $548

> 📌 Previous Analysis: [Berkshire Hathaway Pre-Q2 2026 Earnings Checkpoint: Why a $397B Cash Pile and 1.47x Book Value Still Anchor a $535 Fair-Value Target](https://mybestinvesting.co.kr/?p=2339)

When we last covered Berkshire Hathaway on July 27, 2026, the entire investment debate hinged on one uncomfortable question: what is Greg Abel going to do with a record $397 billion cash pile? For more than a year, the market had treated that mountain of Treasury bills as a drag — capital under-earning in short-term government paper while shareholders waited for a signal that the post-Buffett era would still allocate capital with discipline and opportunism. That question now has a partial, and quite loud, answer. According to a Barron’s analysis of SEC filings published in early August 2026, Berkshire’s Class A share count fell by roughly 11,000 shares between April 14 and July 14, implying the company repurchased up to $11 billion of its own stock in the second quarter — the largest buyback in Berkshire’s history, surpassing the previous $9 billion record set in the fourth quarter of 2020.

This is not a cosmetic update. It is the single most important capital-allocation datapoint since Abel formally took the CEO chair, and it directly refutes the loudest bear argument against the stock — that idle cash and a passive new CEO would let return on equity slowly bleed. A repurchase authorization at Berkshire only triggers when the CEO judges the price to be “below Berkshire’s intrinsic value, conservatively determined.” A record buyback near 1.4–1.5x book value is therefore management’s own signed statement that the stock is cheap. Combined with Abel tripling the Alphabet stake in Q2 and closing the $6.8 billion Taylor Morrison acquisition on July 24, the “cash-drag” thesis is visibly eroding.

This reanalysis carries forward the full investment case for readers meeting the name for the first time (Sections 1–7), then turns to what has changed since our late-July checkpoint and how it reshapes our price targets and exit plan (Sections 8–11). Three points frame everything that follows. First, the record buyback raises the valuation floor: management is now an active, aggressive buyer at current levels, which structurally supports the price near the low end of its historical book-value band. Second, capital deployment has restarted on multiple fronts — buybacks, an equity re-allocation toward Alphabet, and a completed homebuilder acquisition — softening the discount the market applied for “too much idle cash.” Third, the stock has climbed to an eight-month high near $513, only about 7% below our base-case target, so the risk-reward has compressed and now calls for a Hold-and-accumulate stance rather than fresh aggressive buying. With Q2 2026 earnings scheduled for August 8, we recalibrate targets to a base of $548, a bull of $598, and a bear of $468.

—

1. Company Overview

Berkshire Hathaway is not a company in the ordinary sense; it is a diversified holding structure that owns a portfolio of wholly-controlled operating businesses and a large book of publicly-traded equities, all sitting on top of one of the largest insurance operations in the world. Its revenue comes from four broad engines. Insurance — GEICO in auto, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary — generates underwriting profit and, more importantly, “float”: policyholder premiums held before claims are paid. Railroad — BNSF, one of North America’s largest freight networks. Utilities and energy — Berkshire Hathaway Energy, a regulated power and pipeline business. And a sprawling manufacturing, service and retailing (MSR) segment spanning everything from Precision Castparts and Marmon to See’s Candies, Dairy Queen, and the newly-added Taylor Morrison homebuilding operation.

On a trailing-twelve-month basis, Berkshire generated approximately $375.4 billion in revenue and $72.5 billion in GAAP net income (Finviz TTM). A critical caveat, repeated throughout this report: that net-income figure is dominated by mark-to-market gains on the equity portfolio and is not a reliable measure of the underlying business. The number that matters is operating earnings, which strips out the noisy swings from stocks Berkshire has not sold. In the first quarter of 2026 — Abel’s first as CEO — operating earnings rose to $11.34 billion, up roughly 18% year over year, driven by insurance underwriting strength and elevated interest income on the cash pile.

Approximate revenue mix (from the most recent annual filing, rounded): the MSR segment is the largest revenue contributor at roughly half of the total, insurance premiums earned contribute on the order of a quarter, and BNSF and Berkshire Hathaway Energy each contribute high-single-digit percentages, with the remainder from insurance investment income, interest, and other sources. The precise split shifts year to year; readers should treat these as directional proportions rather than exact figures.

Revenue engine	Role	Approx. share of revenue
Manufacturing / Service / Retailing	Owned operating businesses (industrials, consumer, homebuilding)	~50%
Insurance (premiums earned)	GEICO, Reinsurance, Primary — source of float	~25%
BNSF Railroad	Freight rail	~7–8%
Berkshire Hathaway Energy	Regulated utilities and pipelines	~7–8%
Investment & interest income	Dividends, coupons, T-bill yield on cash	Remainder

On market position: GEICO is a top-tier US auto insurer; BNSF is one of two dominant Western US Class I railroads; Berkshire Hathaway Energy is among the largest regulated utility groups in the country. The equity portfolio — roughly $263 billion in US-listed stocks — is led by Apple at about 22% of the portfolio (~228 million shares, ~$60 billion), followed by Alphabet, now the second-largest position at about 6% after Abel tripled the stake in Q2. On governance, the Berkshire structure remains founder-influenced through the dual-class share design, but the operational torch has passed to Greg Abel as CEO, with Warren Buffett continuing as chairman. Total market capitalization sits right at the $1 trillion line (~$995 billion).

—

2. Industry Analysis

2-1. Market Size & Growth Trajectory

Berkshire does not belong to a single industry, which is precisely the point — it is a diversified compounder whose “industry” is capital allocation itself. But its two structural engines, insurance and owned industrial/consumer businesses, sit in enormous end-markets. The global property-and-casualty insurance industry collects well over $2 trillion in premiums annually and continues to grow at a mid-single-digit rate, roughly in line with nominal GDP plus a rate-hardening premium in years of elevated catastrophe losses. US freight rail moves the physical economy; Berkshire Hathaway Energy operates in the multi-decade electrification and grid-investment supercycle. None of these are hyper-growth markets. Berkshire is not, and has never claimed to be, a fast grower. It is positioned in the acceleration-to-maturation phase of stable, cash-generative industries, where the winning strategy is durable margins, low cost of capital, and disciplined reinvestment — not top-line heroics.

The relevant “growth trajectory” for a Berkshire shareholder is therefore not industry TAM expansion but book-value-per-share compounding. Over the long run, Berkshire has grown intrinsic value at a rate meaningfully above inflation by retaining every dollar of earnings and redeploying it — into operating businesses, equities, or, when nothing better is available, its own shares. That last channel is exactly what just fired in Q2 2026, when the company executed the largest repurchase in its history.

2-2. Structural Growth Drivers

Driver 1 — The insurance float engine. Berkshire holds roughly $177 billion of insurance float: money collected as premiums that it can invest before claims come due. When underwriting is profitable — as it has been recently, with Q1 2026 operating earnings up 18% year over year on strong insurance results — the float is effectively negative-cost leverage. Berkshire is paid to hold other people’s money and invest it. No asset manager, private-equity firm, or bank can replicate this structure at Berkshire’s scale and cost. As long as GEICO and the reinsurance operations underwrite to a combined ratio below 100%, the float grows and compounds the entire enterprise. This is the deepest, most durable driver in the business, and it is fundamentally a function of underwriting discipline rather than market cycles. The float has grown for decades, and its cost has stayed negative through multiple hard and soft insurance markets — a track record no competitor can point to.

Driver 2 — Interest income on the cash fortress. For most of the 2010s, Berkshire’s giant cash balance was a genuine drag because short-term rates were near zero. That has flipped. With a cash pile that peaked at a record $397.4 billion and short-term Treasury yields still meaningfully positive, the cash now throws off an estimated low-double-digit-billions of annualized interest income. Shareholders are, in effect, paid to wait for Abel to find a large acquisition. This transforms what used to be a criticism (“why are you hoarding cash?”) into a genuine earnings contributor and a strategic call option on the next market dislocation. The Q1 2026 operating-earnings jump was materially helped by this dynamic. The key nuance for the next twelve months is rate direction: if short rates fall, the cash contributes less, which paradoxically increases the incentive to deploy — a self-correcting pressure that argues for continued capital allocation.

Driver 3 — Capital redeployment optionality under Abel. This is the driver that just changed character. For over a year the bear case was that Abel would sit on the cash. In Q2 2026 he demonstrated the opposite across three channels: (a) a record ~$11 billion buyback, the largest in company history; (b) tripling the Alphabet position from ~2% to ~6% of the US equity portfolio, a decisive bet on cloud and AI monetization; and (c) closing the $6.8 billion Taylor Morrison acquisition on July 24, adding a homebuilding platform. Whether through repurchases, equities, or whole-company deals, capital is moving again. The optionality embedded in the balance sheet is being exercised, not merely admired — and each channel is accretive when executed below intrinsic value, as the buyback authorization requires.

2-3. Competitive Landscape

Berkshire has no true peer, but it is instructive to triangulate against three reference points: large diversified insurers, financial conglomerates, and the S&P 500 index itself.

Comparison	Berkshire Hathaway	Large P&C insurers	Financial conglomerates	S&P 500 (index proxy)
Valuation lens	~1.52x book value	~1.0–2.0x book (varies)	~10–14x earnings	~20–22x forward earnings
Leverage	Very low (Debt/Eq ~0.20)	Moderate	Higher	n/a
Cash optionality	~$397B (record)	Limited	Limited	n/a
ROE	~10.5%	~8–15%	~10–15%	~18–20% (index)
Downside profile	Fortress balance sheet, buyback support	Cyclical underwriting	Credit-cycle exposure	Full market beta

Berkshire’s ROE of ~10.5% is not the highest number in this table — the S&P 500’s index-level ROE is structurally higher because it is weighted toward asset-light megacap technology. But that comparison misses the point of owning Berkshire. What Berkshire offers is downside asymmetry: a fortress balance sheet, negative-cost float, the lowest leverage in the peer set (Debt/Equity ~0.20), and a management team now actively buying back stock below intrinsic value. It is a wealth-preservation compounder that also compounds — a ballast asset, not a beta asset. Against other diversified financials, its cost of capital and float advantage are unmatched; against the index, it offers materially less drawdown risk in exchange for accepting a lower ceiling on returns. In a market trading near record multiples, the value of that asymmetry rises, which is part of why the stock has held near an eight-month high even as the broader debate focuses on stretched valuations elsewhere.

—

3. Economic Moat Analysis

Moat Type 1: Cost advantage via negative-cost float

Berkshire’s primary moat is structural and financial: it funds a large portion of its investment portfolio with insurance float that carries negative cost. When underwriting is profitable, Berkshire is paid to hold ~$177 billion of other people’s money and invest it in businesses and securities. This is a cost-of-capital advantage that compounds silently every year. A private-equity fund pays limited partners; a bank pays depositors and faces runs; an asset manager charges fees but invests clients’ money, not its own balance sheet. Berkshire uniquely invests permanent, low-cost, internally-generated capital. The evidence is in the numbers: operating earnings up 18% year over year in Q1 2026 with underwriting profitability intact, and a float base that has grown for decades. This moat is not a brand or a patent — it is a business-model moat, the hardest kind to replicate because it requires simultaneously operating a disciplined insurer and a world-class capital allocator. Very few institutions on earth do both; none do both at Berkshire’s scale.

Moat Type 2: Scale, reputation, and the “buyer of choice” advantage

Berkshire’s second moat is reputational and structural: it is the acquirer of first call for family-owned and distressed businesses that want a permanent home with no meddling. Sellers accept lower prices for the certainty, speed, and autonomy Berkshire offers. This is a genuine sourcing advantage that lowers Berkshire’s effective purchase multiples. The scale of the balance sheet — a near-$1 trillion enterprise with $397 billion in dry powder — means Berkshire can write a check that almost no other single entity can, whether for a $6.8 billion homebuilder (Taylor Morrison) or a hypothetical multi-tens-of-billions transaction. In periods of market stress, when leveraged buyers disappear, Berkshire’s cash and reputation let it act as the counterparty of last resort. That optionality is worth a premium and is not available to any leverage-dependent competitor. The reputation compounds too: every deal that leaves a founder happy makes the next founder more likely to call Omaha first.

Moat Durability Assessment

Will these moats hold for 5–10 years? The float moat is highly durable so long as underwriting discipline is maintained — the principal risk is a soft insurance market or a catastrophic loss year that pushes the combined ratio above 100% for a sustained period. The sourcing/scale moat is essentially permanent given the balance sheet, but its value depends on management continuing to allocate capital rationally. This is the crux of the post-Buffett transition: the moats are intact, but their monetization now rests on Greg Abel. The Q2 2026 evidence — a record buyback executed only because the price was judged below intrinsic value, plus disciplined equity re-allocation into Alphabet and a sensibly-priced acquisition — is precisely the behavior a Berkshire shareholder wants to see. The single biggest risk to the moat is not competition; it is internal capital-allocation drift. On the freshest available evidence, that risk is receding rather than growing.

—

4. Financial Analysis

Berkshire’s financials must be read through the operating-earnings lens, because GAAP net income swings wildly with the mark-to-market value of its equity book. The table below tracks the metric that actually reflects the business.

Period	Operating earnings	Note
2021	~$27.6B
2022	~$30.9B	resilient despite equity-market volatility
2023	~$37.4B	insurance recovery, higher interest income
2024	~$47.4B	GEICO turnaround + T-bill yield tailwind
Q1 2026	$11.34B	+18% YoY — Abel’s first quarter
TTM GAAP net income	$72.47B	dominated by equity marks — not a valuation input

The trajectory of operating earnings from ~$27.6 billion (2021) to ~$47.4 billion (2024) — a ~72% increase over three years — tells the real story: the underlying business has compounded earnings power steadily, helped enormously by the shift from a zero-rate to a positive-rate environment that turned the cash balance from a drag into a contributor. The Q1 2026 result of $11.34 billion (+18% YoY) shows the momentum continuing into the Abel era.

Key operating metrics: the two numbers a Berkshire analyst watches most are the combined ratio (underwriting profitability — must stay below 100%) and book value per share (the proxy for intrinsic value growth). At a current P/B of 1.52x against a share price of $512.97, implied book value per share is approximately $337. Return on equity runs at ~10.5%, achieved with Debt/Equity of just 0.20 — an unusually low leverage ratio that underscores the fortress nature of the balance sheet.

Balance sheet highlights: the defining feature is the ~$397 billion cash and Treasury position — a record for Berkshire and one of the largest corporate cash positions of any US public company. Against this, total debt is modest (Debt/Equity 0.20). Free cash flow is robust and diversified across insurance, rail, energy, and the MSR segment. This combination — enormous liquid reserves, minimal leverage, and diversified cash generation — is why Berkshire is widely regarded as a “sleep-well-at-night” holding. The Q2 buyback also matters here: repurchasing up to $11 billion of stock reduces the share count, which increases book value per share for the remaining holders whenever the buyback is done below intrinsic value.

Margin profile (TTM): gross margin ~23.7%, operating margin ~16.1%, net margin ~19.3% (the net margin is inflated by equity gains and should be discounted). The margin story here is not about expansion — it is about stability. Berkshire’s diversified base produces remarkably consistent operating margins across cycles, which is the entire point of a ballast asset. Investors buying Berkshire are underwriting predictability, not margin inflection.

—

5. Valuation

Why P/E is the wrong tool here

At first glance, Berkshire looks cheap on a trailing P/E of ~15.3x (on TTM EPS of $33.59) and expensive on a forward P/E of ~23.8x (on consensus EPS-next-year of $21.53). Both figures are misleading. GAAP EPS for Berkshire includes unrealized gains and losses on its ~$263 billion equity portfolio, which can swing earnings by tens of billions of dollars in a single quarter based purely on stock-market moves. The forward EPS estimate of $21.53 is lower than trailing precisely because analysts normalize out the prior period’s equity gains. P/E is not applicable as a primary valuation method for Berkshire. The correct lens is price-to-book value, which the company itself uses to gauge when to repurchase shares.

Price-to-book framework

Berkshire has historically traded in a 1.2x–1.6x book-value band, with management defending the stock via buybacks toward the lower end. Today’s 1.52x sits in the upper-middle of that band. With book value per share near $337 and compounding at roughly 10.5% ROE (partly aided by buybacks executed below intrinsic value), we estimate forward book value per share of approximately $360–$362 by year-end 2026.

Applying scenario multiples to forward book:

– Base case — $548: ~1.51x forward book (~$362). Assumes continued book accretion, buyback support, and a modest narrowing of the “idle-cash” discount now that deployment has restarted. Upside of ~6.8% from $512.97.
– Bull case — $598: ~1.65x forward book. Assumes a hard insurance market lifting underwriting income, further accretive deployment of the cash pile (a large acquisition or continued aggressive buybacks), and the Alphabet stake re-rating higher. This aligns with UBS’s $597 target. Upside of ~16.6%.
– Bear case — $468: ~1.30x forward book. Assumes multiple compression toward the buyback-support zone near the 52-week low of $455, triggered by an underwriting shock or a broad market drawdown that also drags the equity book. Downside of ~8.8%.

Reconciliation with analyst consensus

The Finviz consensus target is $513.64, essentially the current price. A broader poll of about ten analysts averages around $515, with a notable dispersion: UBS’s Brian Meredith sits at $597 (Buy), 24/7 Wall St. models ~$572, S&P Global’s panel averages $520 (Buy), while TD Cowen has been more cautious near $479. Our base case of $548 sits above the average consensus but below the most bullish targets — a deliberate positioning. We are more constructive than consensus because we weight the record buyback heavily as a valuation-floor signal and a management endorsement of intrinsic value; we are less aggressive than UBS because the stock is already near an eight-month high and the P/B multiple has limited room before it reaches the top of its historical band.

—

6. Risk Factors

Risk 1 — Capital-allocation drift in the Abel era. This remains the structural risk, even though Q2 2026 offered strong counter-evidence. Berkshire’s entire premium over a passive index rests on the assumption that management redeploys retained earnings at above-market returns. If Abel were to overpay for a large acquisition — the classic empire-building mistake — or if the cash pile were to keep swelling with no deployment for several more years, return on equity would erode and the stock would de-rate toward the low end of its book-value band. The record buyback and the Taylor Morrison deal argue that discipline is intact, but a single poorly-priced mega-acquisition could damage the compounding thesis for years. This is the risk that most warrants ongoing monitoring, and it is inherently unpredictable because it depends on one executive’s judgment at the moment of a large deal. The market will scrutinize every large check Abel writes for signs of paying up.

Risk 2 — Scale anchor on forward returns. At a ~$1 trillion market capitalization, Berkshire is simply too large to compound at the rates it achieved in earlier decades. The law of large numbers is unforgiving: moving the needle on a trillion-dollar enterprise requires deploying tens of billions of dollars into opportunities that themselves must be enormous and attractively priced — a shrinking set. Realistic forward total returns are in the high-single to low-double digits, not the 20%+ of Berkshire’s youth. Investors who anchor on the historical track record risk disappointment. This is not a risk of loss so much as a risk of opportunity cost — the ceiling on returns is structurally lower than it was, and buyers at an eight-month high must accept that the easy compounding is behind, not ahead.

Risk 3 — Catastrophe losses and portfolio concentration converging. Berkshire’s insurance operations carry genuine tail risk: a severe hurricane season or a mega-catastrophe could produce a large underwriting loss in a single quarter, pushing the combined ratio above 100% and denting book value. Compounding this, the equity portfolio is concentrated — Apple alone is ~22% of the ~$263 billion book. A simultaneous event — a major catastrophe and a drawdown in Apple or the broader market — would hit book value from two directions at once, precisely the scenario that could drive the stock toward the bear-case $468. While the balance sheet is built to absorb such shocks (that is the entire design philosophy), the sentiment impact and the near-term book-value hit are real risks for anyone buying at current levels. Hurricane season, which peaks in the third quarter, makes this risk especially timely heading into the Q2 print and beyond.

—

7. Conclusion & Exit Plan

Investment rating: Hold (accumulate on weakness). Berkshire remains a high-quality ballast holding whose core thesis is not only intact but strengthening — the record buyback and restarted capital deployment directly answer the market’s biggest concern. However, with the stock at an eight-month high near $513, only ~7% below our base-case target and trading in the upper half of its historical book-value band, the risk-reward no longer supports aggressive fresh buying. This is a name to hold as core ballast and add to on pullbacks toward the mid-$460s to mid-$480s.

Entry / accumulation range: $465–$485, where the price approaches the buyback-support zone and the risk-reward versus the base case improves materially.

Exit conditions:
– Target achieved: trim ~30% of the position at the base-case target of $548; trim a further ~25% above the bull-case $598.
– Fundamental break: reduce or exit if the combined ratio stays above 100% for two or more consecutive quarters, if Abel-era ROE drifts toward mid-single digits, if a large acquisition is completed at a visibly excessive price, or if leverage rises materially above Debt/Equity 0.20.
– Time-based: reassess after Q2 2026 earnings (August 8) and again in roughly six months.

Item	Detail
Company	Berkshire Hathaway Inc. Class B (BRK.B)
Current Price	$512.97
Target Price (Base)	$548
Upside	~6.8%
Rating	Hold (accumulate $465–$485)
Key Thesis	Record $11B buyback + restarted deployment refute the idle-cash bear case; fortress balance sheet and negative-cost float anchor a wealth-preservation compounder
Main Risk	Capital-allocation drift or a catastrophe-plus-portfolio drawdown

—

8. What Changed Since Last Analysis

When we published our checkpoint on July 27, 2026, we argued that Berkshire’s fair value was anchored by four ideas. Here is where each stands only about a week later — a short interval, but one that happened to bracket a genuinely material disclosure.

Idea 1 — “The $397B cash pile is pre-positioned optionality earning roughly $12B a year while it waits.” Status: strengthened and partly monetized. At the time we framed the cash purely as a call option. We now have evidence the option is being exercised. The Barron’s estimate of a record ~$11 billion Q2 buyback — the largest in company history, eclipsing the $9 billion Q4 2020 record — plus the closed $6.8 billion Taylor Morrison acquisition (July 24) and the tripling of the Alphabet stake, show cash converting into shareholder value and productive assets. The idle-cash criticism, which was the loudest bear argument, is materially weaker than it was a week ago.

Idea 2 — “~$177B negative-cost insurance float; operating earnings +18% YoY.” Status: unchanged and intact. No new data has emerged to challenge underwriting profitability. The float engine continues to be the deepest moat, and the next read comes with Q2 earnings on August 8. We are watching the combined ratio and hurricane-season exposure, but nothing in the interval has weakened this pillar.

Idea 3 — “1.47x book near the buyback-support floor; ~10.5% ROE at 0.20x leverage.” Status: evolved — the floor is now confirmed and active. A week ago the buyback support was theoretical, inferred from history. The Q2 filing data converts it from theory to fact: management repurchased at record scale precisely in the 1.4–1.5x book zone, formally declaring the price below intrinsic value. The multiple has ticked up from 1.47x to 1.52x as the stock rose, but the mechanism protecting the downside is now demonstrated rather than assumed.

Idea 4 — “GAAP net income is noise; value on operating earnings and book value.” Status: unchanged. This methodological point holds. The forward P/E of 23.8x remains a red herring driven by normalized equity marks; book value remains the correct lens.

New investment idea to surface: the Alphabet re-allocation is a genuinely new angle. Abel tripled the position to ~6% of the US portfolio, making it the second-largest holding after Apple. This signals that the new CEO is willing to make decisive, concentrated equity bets on secular themes (cloud, AI monetization) rather than passively managing an inherited book — a meaningful data point about how the portfolio will evolve under his stewardship.

New risk to flag: with the stock now at an eight-month high, valuation risk has increased at the margin. A week ago the stock sat mid-range versus our targets; today it is within ~7% of base case, so the cushion for new buyers has thinned even as the fundamental thesis has improved. Improving fundamentals and a rising price are pulling in opposite directions for the risk-reward of new capital.

—

9. Current Assessment

At our July 27 checkpoint, the analysis-date price was $495.50. The stock now trades at $512.97, a gain of approximately +3.5% in about a week, driven largely by the market pricing in the record-buyback disclosure and general strength in Berkshire’s top holdings ahead of Q2 earnings. The stock has reached an eight-month high, with a 52-week range of $455.18 to $520.66 — meaning it now sits within roughly 1.5% of its 52-week high.

Relative to the scenario targets we set on July 27 (base $535, bull $588, bear $455), the stock has moved toward the base case: it now sits about 4% below the prior base target and comfortably above the prior bear. None of the three prior targets has been reached, but the direction of travel has been squarely toward fair value, compressing the remaining upside.

Time elapsed since the prior checkpoint is only about a week; time since the original fair-value reanalysis (July 18) is roughly two and a half weeks; and time since the first Abel-era coverage (late June) is a little over a month. The rapid cadence of reviews reflects the scheduled review-deadline gating ahead of Q2 earnings, not a deterioration in the thesis.

Current holding stance: maintaining position. The thesis is intact and, on the capital-allocation dimension, improving. The only reason we do not upgrade to an outright buy is price: near an eight-month high and the upper half of the book-value band, the margin of safety for new capital has narrowed. For existing holders, this is a comfortable hold; for new capital, patience toward the mid-$460s–mid-$480s accumulation zone is the disciplined choice.

—

10. Revised Price Target & Valuation

We continue to value Berkshire on price-to-book, applying scenario multiples to an estimated forward book value per share of approximately $360–$362 (up modestly from the ~$358 used on July 27, reflecting continued book accretion and buyback activity executed below intrinsic value).

The key change versus July 27 is not the book value — which moves slowly — but our willingness to assign a slightly higher multiple in the base and bull cases, and to lift the bear-case floor. The reasoning: the record buyback both (a) demonstrates management’s conviction that intrinsic value exceeds the current price, justifying a modestly higher base multiple, and (b) raises the practical downside floor, because management is now an active, large-scale buyer whenever the price approaches the low end of the band.

Scenario	Previous Target (Jul 27)	Revised Target	Change	Key Driver
Base Case	$535	$548	+2.4%	Forward book ~$362 at ~1.51x; restarted deployment narrows idle-cash discount; buyback accretion
Bull Case	$588	$598	+1.7%	~1.65x forward book on hard insurance market + accretive deployment + Alphabet re-rating; aligns with UBS $597
Bear Case	$455	$468	+2.9%	Buyback floor raised — management repurchasing at record scale near the 52-week-low zone lifts the practical downside

What drove the changes: the upward revisions are deliberately modest (1.7%–2.9%) because the underlying book value has barely moved in a week — this is a re-rating of confidence, not a change in the fundamentals. The record buyback is the single justification: it simultaneously validates the intrinsic-value case (supporting a higher base multiple) and hardens the downside (supporting a higher bear floor). We explicitly resisted a larger increase because the stock is near an eight-month high and the P/B multiple is approaching the top of its historical range, which caps near-term multiple expansion.

Versus consensus: our base of $548 sits above the Finviz consensus ($513.64) and the roughly ten-analyst average (~$515), but below the most bullish targets (UBS $597, 24/7 Wall St ~$572). We are comfortable being above the average because consensus appears to under-weight the buyback signal; we are comfortable being below the bulls because valuation-and-timing discipline argues against chasing the stock at a multiyear high.

—

11. Updated Exit Plan

Recommended stance: continue holding; add only on weakness. For existing holders, Berkshire remains a core ballast position whose thesis has strengthened on the capital-allocation front. There is no reason to reduce on fundamentals. For investors without a position or looking to add, the disciplined entry is on pullbacks toward the $465–$485 accumulation zone rather than at the current eight-month high.

Staged exit plan by price:
– Trim approximately 30% of the position at the base-case target of $548.
– Trim a further approximately 25% if the bull-case $598 is reached.
– Retain the remaining core position as long-term ballast, given the fortress balance sheet and negative-cost float.

Accumulation plan: add in tranches in the $465–$485 range, provided underwriting and ROE remain intact — this is the zone where management’s own buyback activity provides a soft floor.

Updated stop-loss / impairment triggers — conditions that would break the core thesis:
– Combined ratio persistently above 100% for two or more consecutive quarters (underwriting/float moat breaking).
– Abel-era ROE drifting toward mid-single digits (capital-allocation drift materializing).
– A large acquisition completed at a visibly excessive price (empire-building risk).
– Leverage rising materially above Debt/Equity 0.20 (balance-sheet fortress eroding).

Next review date: immediately after Q2 2026 earnings on August 8, 2026 — with specific attention to the confirmed buyback figure (versus the ~$11B estimate), the combined ratio, cash-pile trajectory, and any commentary on further deployment — and a broader reassessment roughly six months out.

One-sentence summary: For current holders, we recommend continuing to hold Berkshire as core ballast into Q2 earnings while raising the base-case target to $548 on the strength of a record buyback, and reserving fresh capital for pullbacks toward the mid-$460s to mid-$480s.

—

This article is for informational purposes only and does not constitute investment advice. All data sourced from public filings, analyst reports, and news as of the publication date. Invest at your own discretion.

This content is general investment information provided to an indefinite/unspecified audience by a quasi-investment advisory business registered under Korea’s Financial Investment Services and Capital Markets Act, and is not personalized 1:1 investment advice tailored to any individual investor. This analysis is for informational purposes only and is not a solicitation to invest. All investment decisions and their consequences rest solely with the investor. The estimates and assumptions in this report are as of the writing date (2026-08-04) and may not materialize depending on market conditions and geopolitical variables. Financial data used reflects sources such as company filings and analyst consensus, and the scenarios and price targets represent the author’s conservative assessment. All investments carry the risk of principal loss, and past performance or analytical track record does not guarantee future results. As of the writing date, the author currently holds a position in this stock; this article is a review of an actual position. The author’s holdings and positions may change without prior notice depending on market conditions.